Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration

BMC Neurology

Volumn 6, Issue , 2006, Pages

  Borroni, Barbara ^a   Perani, Daniela ^b   Archetti, Silvana ^a   Agosti, Chiara ^a   Paghera, Barbara ^c   Bellelli, Giuseppe ^d   Di Luca, Monica ^e   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Brescia Civic Hospital   (Italy)

^d Ancelle della Carita Hospital   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; AMNESIA; ARTICLE; BRAIN FUNCTION; CLINICAL FEATURE; DEGENERATIVE DISEASE; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; LABORATORY TEST; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; APOLIPOPROTEINS E; BRAIN ISCHEMIA; CROSS-SECTIONAL STUDIES; DEMENTIA; GENOTYPE; HETEROZYGOTE; HUMANS; MEMORY; MIDDLE AGED; PARAHIPPOCAMPAL GYRUS;

EID: 33748902278     PISSN: 14712377     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-6-31     Document Type: Article

References (31)

1. Kertesz A, Munoz DG: Pick's disease and Pick complex. Wiley-Liss, New York; 1998.
2. Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J: Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain 2005, 128:597-605.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell FTLD, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
4. Schott J, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC: Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Arch Neurol 2006, 63:157-158.
5. Lantos PL: Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry 2000, 69:705-706.
6. Litvan I, Agid Y, Calne D, Campbell G, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
7. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
8. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-98.
9. Bingham WC, Burke HR, Murray S: Raven's Progressive Matrices: construct validity. J Psycgol 1966, 62:205-9.
10. Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973, 123:467-470.
11. Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS: Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc 1989, 37:730-4.
12. Loring DW, Martin RC, Meador KJ: Psychometric construnction of the Rey-Osterrieth Complex Figure. Arch Clin Neuropsych 1990, 5:1-14.
13. Babcock H, Levy L: The measurement of mental efficiency of mental functioning (revised examination). In Test and manual of directions Chicago: CH Stoelting; 1940.
14. Blackburn HL, Benton AL: Revised administration and scoring of the digit span test. J Consult Psychol 1957, 21:139-43.
15. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and motor skills 1958, 8:271-76.
16. De Renzi E, Vignolo LA: The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain 1962, 85:665-78.
17. De Renzi E, Motti F, Nichelli P: Imitating gestures. A quantitative approach to ideomotor apraxia. Arch Neurol 1980, 37:6-10.
18. Lawton MP, Broody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist 1969, 9:179-186.
19. Sheikh K, Smith DS, Meade TW, Goldenberg E, Brennan PJ, Kinsella G: Repeatibility and validity of a modified Activities of Daily Living (ADL) Index in studies of chronic disability. Int Rehabil Med 1979, 1:51-58.
20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-14.
21. Kertesz A, Nadkarni N, Davidson W, Thomas AW: The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 2000, 6:460-8.
22. Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A, European Association of Nuclear Medicine: European Association of Nuclear Medicine. European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals. Eur J Nucl Mol Imaging 2002, 29:BP36-42.
23. Friston KJ: Testing for anatomically specified regional effects. Hum Brain Mapp 1997, 5:133-6.
24. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A: MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 2004, 63:2332-2340.
25. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allelle of apolipoprotein E. New Eng J Med 1996, 334:752-758.
26. Borroni B, Yancopoulou D, Tsutsui M, Padovani A, Sawcer SJ, Hodges JR, Spillantini MG: Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol 2005, 62:1419-1422.
27. Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G: (1997) Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 1997, 8:240-243.
28. Srinivasan R, Davidson Y, Gibbons L, Payton A, Richardson AM, Varma A, Julien C, Stopford C, Thompson J, Horan MA, Pendleton N, Pickering-Brown SM, Neary D, Snowden JS, Mann DM: The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 2006, 77:154-8.
29. Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M: Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol 2002, 59:611-5.
30. Fabre SF, Forsell C, Viitanen M, Sjogren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund LO, Lannfelt L: Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol 2001, 168:413-8.
31. Geschwind D, Karrim J, Nelson SF, Miller B: The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 1998, 44:134-8.